# US 2022/0047684 A1 · Enzymes and methods for preventing and treating pyrethroid exposure in animals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0047684 A1
- Document ID: US20220047684A1
- Status: Published application
- Kind: A1
- Application number: 17/520,849
- Filed: 2021-11-08
- Published: 2022-02-17
- Earliest claimed: 2020-06-04
- Assignees: Ecto Development Corporation
- Applicants: Ecto Development Corporation
- Inventors: Bobby Rose; Rich Rose; Brian Compton; Ashley Siegel; Alejandro Tovar-Mendez
- Web page: https://patentgrep.com/patent/US20220047684A1

## CPC

- A61K 38/465: {acting on ester bonds (3.1), e.g. lipases, ribonucleases}
- C12Y 301/01088: Pyrethroid hydrolase (3.1.1.88)
- A61P 39/00: General protective or antinoxious agents
- C12N 9/18: Carboxylic ester hydrolases {(3.1.1)}
- C12Y 301/01001: Carboxylesterase (3.1.1.1)
- C07K 2319/21: containing a His-tag
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12Y: ENZYMES
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Compositions and methods for treating an animal who has been exposed to pyrethroid are provided. An effective amount of a pyrethroid detoxifying enzyme to prevent or treat pyrethroid toxicity. The pyrethroid detoxifying enzyme is one or more pyrethroid-hydrolyzing carboxylesterases.

## Claims

### Claim 1

A method for treating an animal who has been exposed to pyrethroid comprising administering an effective amount of a pyrethroid detoxifying enzyme to prevent or treat pyrethroid toxicity.

### Claim 2 (depends on 1)

The method of claim 1, wherein the pyrethroid detoxifying enzyme is one or more hydrolyzing carboxylesterases.

### Claim 3 (depends on 1)

The method of claim 1 wherein the animal is selected from the group consisting of an aquatic species, a poultry species, a porcine species, a bovine species, an ovine species, an equine species, and a companion animal.

### Claim 4 (depends on 3)

The method of claim 3 wherein the animal is a companion animal.

### Claim 5 (depends on 4)

The method of claim 4 wherein the animal is a canine species or a feline species.

### Claim 6 (depends on 5)

The method of claim 5, wherein the animal is a feline species.

### Claim 7 (depends on 1)

The method of claim 1, wherein the pyrethroid is one or more of pyrethrin, tetramethrin, allethrin, phenothrin, barthrin, dimethrin, bioresmethrin, permethrin fenpropathrin, bifenthrin, cyfluthrin, beta-cylfuthrin, phenothrin, imiprothrin, flumethrin, momfluorothrin, bioallethirn, deltamethrin, cypermethrin, and tetramethrin.

### Claim 8

A composition for the administering to an animal who has been exposed to pyrethroid, the composition comprising a pharmaceutical carrier suitable for administration in an animal and an effective amount of a hydrolyzing carboxylesterase.

### Claim 9 (depends on 8)

The composition of claim 8, wherein the composition is administered to an animal is selected from the group consisting of an aquatic species, a poultry species, a porcine species, a bovine species, an ovine species, an equine species, and a companion animal.

### Claim 10 (depends on 9)

The composition of claim 9, wherein the animal is a companion animal.

### Claim 11 (depends on 10)

The composition of claim 10, wherein the animal is a feline species.

### Claim 12 (depends on 8)

The composition of claim 8, wherein the animal has been exposed to is one or more of pyrethrin, tetramethrin, allethrin, phenothrin, barthrin, dimethrin, bioresmethrin, permethrin, fenpropathrin, bifenthrin, cyfluthrin, beta-cylfuthrin, phenothrin, imiprothrin, flumethrin, momfluorothrin, bioallethirn, deltamethrin, cypermethrin, and tetramethrin.

### Claim 13

A method for treating an animal to prevent pyrethroid toxicity, the method comprising: administering an effective amount of a pyrethroid detoxifying enzyme to prevent pyrethroid toxicity.

### Claim 14 (depends on 13)

The method of claim 13, further comprising: administering an effective amount of a one or more hydrolyzing carboxylesterases to an animal to prevent the toxic effect of synthetic pyrethroids.

### Claim 15 (depends on 14)

The method of claim 14, wherein the administration of an effective amount of one or more hydrolyzing carboxylesterases is done before the animal is exposed to pyrethroids.

### Claim 16 (depends on 15)

A method of claim 15, wherein administering an effective amount of one or more hydrolyzing carboxylesterases an animal to reduces the toxic effect of synthetic pyrethroids.

### Claim 17 (depends on 13)

The method of claim 13, wherein the pyrethroid detoxifying enzyme is one or more hydrolyzing carboxylesterases.

### Claim 18 (depends on 13)

The method of claim 13, comprising feeding an animal, the method comprising the step of administering to the animal a feed composition or drinking water comprising an effective amount of an additive one or more hydrolyzing carboxylesterases wherein the one or more hydrolyzing carboxylesterases causes an effect selected from the group consisting of preventing or treating pyrethroid toxicity.

### Claim 19 (depends on 13)

The method of claim 13, comprising administering to the animal an effective amount of hydrolyzing carboxylesterase by injection.

### Claim 20 (depends on 13)

The method of claim 13, comprising administering to the animal an effective amount of hydrolyzing carboxylesterase by topical administration.
